The primary objectives of this study are to evaluate the efficacy and safety of 2 SC dosing tiers of ustekinumab in the treatment of adolescent subjects 12 to 18 years of age with moderate to severe chronic plaque psoriasis
Data and Resources
- A Phase 3 Multicenter Randomized Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Adolescent Subjects With Moderate to Severe Plaque-type Psoriasisjson
The primary objectives of this study are to evaluate the efficacy and safety...
Download
Field | Value |
---|---|
Modified | 2019-10-30 |
Release Date | 2019-04-19 |
Identifier | 04a5c8cf-e4a0-439a-a4ec-a39a143cad1e |
License | License Not Specified |
Public Access Level | Public |